fbpx

Bold. Sleek. Ferragamo.

Voila Optik September-October 2025 Marchon Ferragamo SF323SG

A bold fusion of fashion and function, model SF323SG colour 751 – Deep Gold features an aviator-style silhouette with an integrated prism hinge. Gently curved lenses are accented by linear motifs along the gold-tone temples and borders, while Ferragamo’s iconic Gancini pattern adds unmistakable elegance across the amber-tinted visor.

Distributed by Marchon: www.marchon.com

About Marchon:

Working with leading brands to constantly push the envelope through distinct designs, innovative materials and clever constructions, Marchon Eyewear’s goal is to consistently design distinctive eyewear that offers accessible quality, style and value.

Marchon is proud of its diversified portfolio of brands, covering key demand segments in the premium end of the market.

Marchon Eyewear distributes its products through a global network of subsidiaries and distributors, serving over 80,000 accounts in more than 100 countries.

Whether helping people access quality care, supporting eye care providers in managing their practice, or partnering with local organizations to aid our communities, VSP Vision™ is there with a comprehensive portfolio of brands that keep health at the center of everything we do. As the first not-for-profit eye health company, care and compassion have led our growth for nearly 70 years. Today, our focus remains on helping those we serve bring their best vision to life.

Want to see more like this article? Click here to subscribe to our FREE print magazines and e- newsletters!

Be Iconic, Beyond Limits: J.F. Rey Marks 40 Years of Bold Eyewear Innovation

JF Rey image campagne sept 2025 et logo 40 ans

French eyewear brand J.F. Rey is celebrating its 40th anniversary, reaffirming the values that have defined its journey: independent creativity, excellence in craftsmanship, and a bold, unmistakable style that has become a global eyewear icon.

From its beginnings, J.F. Rey has embraced a singular vision—free from convention and unapologetically daring. Four decades later, that spirit continues to drive the brand’s innovation and shape its identity. The latest anniversary collection represents the culmination of this creative heritage, designed to resonate with today’s high-end market while staying true to its roots.

The new collection spans men’s, women’s, optical, and sun lines, each with a distinct personality defined by signature aesthetics and exclusive technologies. The designs balance technical mastery and striking visual identity, offering a fresh evolution of J.F. Rey’s iconic forms.

Among the highlights:

  • SLEDGE series – A showcase of masculine excellence, with bold lines, uncompromising strength, and patented screwless hinges.
  • Women’s models – More sensitive, accessible, and versatile, featuring gradient effects that introduce a fresh chromatic signature for the season.
  • CARBON INSIDE line – A creative breakthrough with unprecedented coloring of select wood veneers, blending natural materials with avant-garde design.

Color remains central to the brand’s DNA, with deep autumnal shades, metallic effects, and original contrasts adding richness and depth to the collection.

J.F. Rey will present the collection at SILMO Paris (Hall 7 – Booth C129).

👉 More information: jfrey.fr

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

The Vision Council Releases New Report on Myopia Treatment Trends

The Vision Council logo

The Vision Council has released a new two-part research report, Focused inSights 2025: Myopia Management, offering a combined global and U.S. perspective on pediatric myopia treatment. The dual-format report compares regulatory and product availability trends internationally with survey data from U.S. eyecare providers, creating one of the most comprehensive views of current approaches to childhood myopia care.

Comparative Myopia Treatment Strategies

The first section examines treatment availability across the U.S., Canada, the U.K., and the EU, with a focus on four major categories: low-dose atropine drops, myopia control spectacle lenses, multifocal or dual-focus daily soft contact lenses, and orthokeratology.

The report highlights uneven adoption across markets, noting milestones such as the EU’s approval of Ryjunea atropine drops and France’s decision to fully reimburse myopia control spectacle lenses. It also considers financing models and prescribing practices across different regions.

Provider Approaches in the U.S.

The second section presents findings from a survey of 293 U.S. optometrists, practice owners, and managers conducted between June 16 and July 4, 2025. Key insights include:

  • Proactive screening: 91% of providers recommend myopia screenings at least once a year.
  • Treatment adoption: About 70% of providers report offering myopia management to children in their practice.
  • Most common treatment: MiSight® contact lenses are prescribed most frequently (81%).
  • Motivations: Providers cite slowing progression (78%), reducing complication risks (78%), and improving long-term eye health (71%) as leading reasons to treat.
  • Risk factors: Excessive screen time (82%), genetics (82%), and limited outdoor activity (77%) were identified as the main drivers of myopia.
  • Challenges: Cost (86%), parental understanding (56%), and patient compliance (49%) remain significant barriers.

“This dual-format report provides both a global and a local lens on myopia management,” said Alysse Henkel, Vice President of Research and inSights at The Vision Council. “It’s clear that U.S. providers take myopia seriously, but they also face challenges in affordability and patient education. By including an international analysis, we can see where care stands today and where it is headed.”

The full report is available through The Vision Council’s Research Download Center. Members may access the report at no cost; non-members can purchase it for $5,000.

Source: The Vision Council

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

Neurolens Rebrands as Newton, Signaling Next Phase of Optical Innovation

Neurolens rebrands as Newton logo

Neurolens, known for developing Contoured Prism™ technology to address binocular vision issues, has officially rebranded as Newton™. The company says the change reflects a strategic evolution and renewed focus on innovation in eye care.

The new name pays homage to Sir Isaac Newton, widely regarded as one of history’s most influential scientists in mathematics, physics, astronomy, and optics. Company leaders say this spirit of discovery aligns with Newton’s mission to challenge conventional standards in optometry and uncover new possibilities in vision care.

From Neurolens to Newton

Neurolens launched over a decade ago following research into how binocular vision impacts the trigeminal nerve, particularly during near vision tasks. Its Contoured Prism technology was designed to help eyes work together more comfortably, alleviating symptoms such as headaches, neck pain, and eye strain.

Clinical studies show that approximately 90% of patients report relief from symptoms related to eye misalignment after wearing Neurolenses. The company has since expanded beyond neurology clinics to serve hundreds of thousands of patients across North America.

A New Era of Innovation

As Newton, the company says it will continue supporting optometry practices while introducing new technologies later this month. “Newton represents more than a rebrand—it signals the next chapter in transforming eye care beyond 20/20,” said Davis Corley, CEO. “We don’t just meet expectations—we set new ones.”

Dr. Evie Lawson, an optometrist in Seattle who prescribes Neurolenses, said the technology has been “practice-changing” for her and life-changing for patients. “Newton represents the next level of innovation in eye care, consistently supporting optometry to deliver optimized patient experiences,” Lawson said.

The rebrand positions Newton as an innovation company focused on redefining eye care through patient-centered outcomes and advanced technologies.

Full announcement: Neurolens Rebrands as Newton – PR Newswire

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

Study Finds XIIDRA May Improve Comfort for Symptomatic Contact Lens Wearers

Bausch + Lomb

Results from a new investigator-initiated study suggest that XIIDRA® (lifitegrast ophthalmic solution 5%), a prescription drop approved for dry eye disease, may help reduce end-of-day eye dryness and discomfort among symptomatic contact lens wearers.

The study, conducted at the Centre for Ocular Research & Education (CORE) at the University of Waterloo and published in Clinical Ophthalmology, followed 40 participants over 12 weeks. Participants continued wearing their usual contact lenses while using XIIDRA twice daily.

Key Findings

  • Significant improvement in symptoms: After 12 weeks, median scores for end-of-daydryness and discomfort improved by 61 and 59 points, respectively, on a 100-point scale.
  • Early response: Nearly half of participants reported reduced symptoms after just two weeks of treatment, to the extent they would no longer have met study eligibility.
  • Longer wear time: Comfortable lens wear increased by an average of 2.6 hours (from 6.5 to 9.1 hours), though total wear time did not change.
  • Broad symptom relief: Improvements were noted in burning/stinging, itching, foreign body sensation, light sensitivity, and pain.
  • Safety profile: XIIDRA was generally well tolerated, with only two reports of treatment-related adverse events.

Dr. Marc-Matthias Schulze, principal investigator and senior clinical scientist at CORE, noted that improvements were evident as early as two weeks and continued throughout the study. “Results showed that continued use of XIIDRA further improved symptoms, demonstrating that it may allow contact lens wearers to enjoy their lenses throughout the entire day,” he said.

Study Limitations

The study was single-center, open-label, and lacked a control group. Investigators caution that frequent use of prescription drops compared with occasional use of over-the-counter rewetting drops may have contributed to symptom improvements. As such, findings should be interpreted within the limits of the study design, and no formal conclusions can be drawn.

Background

XIIDRA is approved for the treatment of signs and symptoms of dry eye disease. While over-the-counter rewetting drops often provide only temporary relief for contact lens wearers, this study indicates that XIIDRA may represent an alternative option for those with persistent discomfort.

Source: Bausch + Lomb

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

Featured Posts

Alcon logo

Alcon Launches PRECISION7 One-Week Replacement Contact Lenses in Canada

Alcon announces the Canadian launch of PRECISION7, a one-week replacement contact lens designed to deliver comfort, hydration, and an intuitive replacement schedule.

Learn More
Seeing with the Heart - Article Header

Seeing with the Heart: The Power of Giving Back

Explore how Emotional Intelligence (EQ) and charity transform eye care. Learn to build patient trust, reduce burnout, and strengthen your team dynamics.

Read more
The Vision Council logo

U.S. Optical Industry Reaches $69.5 Billion Despite Declines in Product Volume and Eye Exams

The U.S. optical industry reached $69.5 billion in 2025 despite declines in product volume and eye exams, according to Market inSights from The Vision Council.

Read more
contact lens institute

Contact Lens Institute Names 2026 Visionaries

The Contact Lens Institute has named 17 optometrists and opticians from the U.S. and Canada as its 2026 Visionaries, recognizing leaders in contact lens education and best practices.

Read more
BonLook logo 2026

BonLook Ranks at the Top of its Category in Léger WOW Study

BonLook ranks first among eyewear retailers in the 2026 Léger WOW Study, earning top marks for customer experience and digital performance across Canada.

Read more
Alcon logo

Alcon Launches PRECISION7 One-Week Replacement Contact Lenses in Canada

Alcon announces the Canadian launch of PRECISION7, a one-week replacement contact lens designed to deliver comfort, hydration, and an intuitive replacement schedule.

Learn More
Seeing with the Heart - Article Header

Seeing with the Heart: The Power of Giving Back

Explore how Emotional Intelligence (EQ) and charity transform eye care. Learn to build patient trust, reduce burnout, and strengthen your team dynamics.

Read More
The Vision Council logo

U.S. Optical Industry Reaches $69.5 Billion Despite Declines in Product Volume and Eye Exams

The U.S. optical industry reached $69.5 billion in 2025 despite declines in product volume and eye exams, according to Market inSights from The Vision Council.

Read More
contact lens institute

Contact Lens Institute Names 2026 Visionaries

The Contact Lens Institute has named 17 optometrists and opticians from the U.S. and Canada as its 2026 Visionaries, recognizing leaders in contact lens education and best practices.

Read More
BonLook logo 2026

BonLook Ranks at the Top of its Category in Léger WOW Study

BonLook ranks first among eyewear retailers in the 2026 Léger WOW Study, earning top marks for customer experience and digital performance across Canada.

Read More
Alcon logo

Alcon Launches PRECISION7 One-Week Replacement Contact Lenses in Canada

Alcon announces the Canadian launch of PRECISION7, a one-week replacement contact lens designed to deliver comfort, hydration, and an intuitive replacement schedule.

Learn More
Seeing with the Heart - Article Header

Seeing with the Heart: The Power of Giving Back

Explore how Emotional Intelligence (EQ) and charity transform eye care. Learn to build patient trust, reduce burnout, and strengthen your team dynamics.

Read more
The Vision Council logo

U.S. Optical Industry Reaches $69.5 Billion Despite Declines in Product Volume and Eye Exams

The U.S. optical industry reached $69.5 billion in 2025 despite declines in product volume and eye exams, according to Market inSights from The Vision Council.

Read more
contact lens institute

Contact Lens Institute Names 2026 Visionaries

The Contact Lens Institute has named 17 optometrists and opticians from the U.S. and Canada as its 2026 Visionaries, recognizing leaders in contact lens education and best practices.

Read more
BonLook logo 2026

BonLook Ranks at the Top of its Category in Léger WOW Study

BonLook ranks first among eyewear retailers in the 2026 Léger WOW Study, earning top marks for customer experience and digital performance across Canada.

Read more
Alcon logo

Alcon Launches PRECISION7 One-Week Replacement Contact Lenses in Canada

Alcon announces the Canadian launch of PRECISION7, a one-week replacement contact lens designed to deliver comfort, hydration, and an intuitive replacement schedule.

Learn More
Seeing with the Heart - Article Header

Seeing with the Heart: The Power of Giving Back

Explore how Emotional Intelligence (EQ) and charity transform eye care. Learn to build patient trust, reduce burnout, and strengthen your team dynamics.

Read more
The Vision Council logo

U.S. Optical Industry Reaches $69.5 Billion Despite Declines in Product Volume and Eye Exams

The U.S. optical industry reached $69.5 billion in 2025 despite declines in product volume and eye exams, according to Market inSights from The Vision Council.

Read more
contact lens institute

Contact Lens Institute Names 2026 Visionaries

The Contact Lens Institute has named 17 optometrists and opticians from the U.S. and Canada as its 2026 Visionaries, recognizing leaders in contact lens education and best practices.

Read more
BonLook logo 2026

BonLook Ranks at the Top of its Category in Léger WOW Study

BonLook ranks first among eyewear retailers in the 2026 Léger WOW Study, earning top marks for customer experience and digital performance across Canada.

Read more